Markers of Memory CD8 T Cells Depicting the Effect of the BNT162b2 mRNA COVID-19 Vaccine in Japan

BNT162b2, a nucleoside-modified mRNA vaccine for SARS-CoV-2 spike glycoprotein (S), provides approximately 95% efficacy for preventing COVID-19. However, it remains unclear how effectively memory CD8+ T cells are generated and which genetic and environmental factors affect the generation and functio...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Hiroyuki Kondo, Takahiro Kageyama, Shigeru Tanaka, Kunihiro Otsuka, Shin-ichi Tsukumo, Yoichi Mashimo, Yoshihiro Onouchi, Hiroshi Nakajima, Koji Yasutomo
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2022-04-01
סדרה:	Frontiers in Immunology
נושאים:	COVID-19 T cell CD8, vaccine markers antigen
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.836923/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!